Literature DB >> 29096694

Pattern of neurological diseases in adult outpatient neurology clinics in tertiary care hospital.

Safia Awan1, Saad Shafqat1, Ayeesha Kamran Kamal1, Aziz Sonawalla1, Sarwar Siddiqui1, Fowzia Siddiqui1, Mohammad Wasay2,3.   

Abstract

OBJECTIVES: The burden of neurological diseases in developing countries is rising although little is known about the epidemiology and clinical pattern of neurological disorders. The objective of this study was to understand the burden of disease faced by neurologists a in tertiary care setting.
RESULTS: A prospective observational study was conducted of all presentations to neurology clinics at Aga Khan University Hospital Karachi over a period of 2 years. A total of 16,371 out-patients with neurological diseases were seen during the study period. The mean age of the study participants were 46.2 ± 18.3 years and 8508 (52%) were male. Headache disorders were present in 3058 (18.6%) of patients followed by vascular diseases 2842 (17.4%), nerve and root lesions 2311 (14.1%) and epilepsies 2055 (12.5%). Parkinson's disease was more prevalent in male participants 564 (70.8%) as compared to female 257 (62.1%) (p = 0.002). Migraines and vertigo disease were more diagnosed in females as compared to males. Epilepsies were seen more in younger age groups. Parkinson's disease was seen in 50.9% of participants between the ages of 45 and 65 years, and the frequency increased with age.

Entities:  

Keywords:  Clinical pattern; Developing countries; Epidemiology; Neurological disorders

Mesh:

Year:  2017        PMID: 29096694      PMCID: PMC5667470          DOI: 10.1186/s13104-017-2873-5

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


Introduction

Neurological disorders (NDs) are increasing because of demographic and epidemiologic changes occurring in both developed and developing countries. Neurological disorders accounted for 3.0% of global disability-adjusted life-years (DALYs); mainly due to epilepsy and migraines. While in some regions dementia was a major cause, at the global level NDs accounted for 11.3 million DALYs [1]. The overall burden of neurological disorders significantly increases among adults in low- and middle-income countries (LMICs) [2]. Regional differences in neurologic disorders and stroke related risk of death are smaller at older ages than at younger ages, ranging from around 40 to 60% in the developed countries and 70% in sub-Saharan Africa [1, 3, 4]. The Global Burden of Disease 2010 data suggests that non communicable diseases (NCDs) and injuries account for 77% of age standardized deaths in Pakistan [5]. The burden of neurological diseases in developing countries is rising and it is important to know the disease prevalence and pattern based on geographical, social, cultural, religious, and ethnic factors. A population based study conducted in India found 3355 individuals with neurological disorders per 100,000 populations. The most frequent disorders were headache, febrile convulsions, epilepsy, stroke and mental retardation [6]. A study conducted in Saudi Arabia showed that the crude prevalence of neurological disorders was 131/1000 population. Headache, epilepsy, febrile convulsions and mental retardation were common as compared to stroke, dementias and Parkinson’s disease [7]. The available information on the pattern and frequency of major neurological disorders in Pakistan is limited to hospital-based populations who may not be totally representative of the community. The incidence or prevalence of neurological diseases in Pakistan is not known [8]. However the Global Burden of Disease 2010 data suggests that more than half of disability due to neurological diseases is related to stroke followed by dementias, migraine, epilepsy and tetanus [9]. The estimated prevalence of people with dementia in Pakistan is around 200,000. The estimated volume of visits to neurology clinics in Pakistan is close to 200,000 visits per year. The demographics and diagnosis of these patients may vary from area to area. A data base of demographics and diagnosis of outpatients seen at neurology clinics at a tertiary care hospital not only identifies the frequency of different neurological diseases but also includes patient details such as gender and age groups. Findings from this database may open up avenues for further research, particularly in the development of community based studies and interventions/clinical trials to help improve the health of the population.

Aims and objectives

The overall aim of the study was to generate knowledge about neurological disorders NDs in patients attending neurologic clinics in a low-income setting and to contribute the neglected public health field in Pakistan. The main objective of the study was to estimate the frequency of the main NDs in outpatient neurological clinics at a tertiary care hospital in Karachi

Main text

Methods

Study design and setting

The records of all out-patients (18 years and above) seen in neurological clinics were collected at Aga Khan University (AKU) hospital from January 2014 to December 2015. A retrospective observational study was conducted of all presentations to neurology clinics over a period of 2 years. The study was approved by the Ethical Review Committee (ERC) of the Aga Khan University.

Data collection

The WHO protocol for the detection of major neurological disorders was used as the basis for the questionnaire. The questionnaire was tested and modified to suit the needs of this study. The questionnaire was designed to collect data on demographics including age, sex, place and type of residence (rural/urban), referral and patient’s evaluation status (new versus follow-up patient). A diagnosis as a referenced neurology case was determined by neurologist after conducting a physical examination of the patient. The main types of NDs along with sub-group were offered in the questionnaire to record the exact neurological disorder [10]. Uniform and standard criteria was used by neurologists for the diagnosis of cases. For each disorder, WHO classifications and definitions were used to assess the neurological disorder as follows. (1) Vascular diseases, (2) CNS infections, (3) demyelinating diseases, (4) movement disorders, (5) cerebellar ataxias and hereditary spastic paraplegias, (6) CNS neoplasms, (7) dementias, (8) epilepsies, (9) headache disorders, (10) nerve and root lesions, (11) myopathies/muscle disorders, (12) spinal disorders, (13) acquired metabolic and toxic disorders, (14) psychiatric disorders, (15) developmental disorders, and (16) neurometabolic/nutritional disorders of the nervous system. The diagnoses were made clinically with laboratory and radiological confirmation. Radiological tests used included CT-scans (brain and spine), spine X-rays, and MRI. Electrophysiological tests included electroencephalography (EEG), electroneuromyography (ENMG), and electrocardiography (ECG).

Statistical analysis

Descriptive analysis for demographic variables was performed; results were reported as numbers with percentages for quantitative variables, and mean ± standard deviation or median with ranges for all qualitative variables. Comparison between different age groups and gender with neurological diseases were performed using Pearson Chi square test. p < 0.05 was considered as statistically significant; all p values were two sided. SPSS 19.0 (SPSS Inc., Chicago: IL, USA) was used for data entry and analysis.

Results

A total of 16,371 out-patients with neurological diseases were seen during the study period. The mean age of the study participants was 46.2 ± 18.3 years with median of 46 years. Patients over 40 years made up 8389 (51.2%) of the participants. A total of 8508 (52%) were male and 7867 (48.1%) were female. The frequency of various neurological disorder groups is shown in Table 1. Headache disorders were present in 18.6% of patients followed by vascular diseases 17.4%, nerve and root lesions 14.1%, epilepsies 12.5%, psychiatric disorders 11.7% and neurometabolic/nutritional disorders 11.3%. Among the vascular group stroke was presented in 2792 (98.2%) of patients. The most common sub type was ischaemic stroke 2277 (81.6%) followed by haemorrhagic stroke 294 (10.5%). Migraine 1698 (55.5%) was the most common presentation amongst the headache disorder group. The most common presentation among the sleep disorders group was obstructive sleep apnoea 105/195 (53.8%) followed by restless leg syndrome 87/195 (44.6%). Among the CNS infections group, tuberculous meningitis 162 (65.3%), viral meningitis 44 (17.7%) and bacterial meningitis 32 (12.9%) were the most common presentations. The dementia group is mainly constituted of two types of diseases; Alzheimer’s 211 (45.8%) followed by dementia 207 (45%). Among movement disorders, Parkinson’s disease 821 (67.7%) was the most common presentation, followed by dystonia 141 (11.6%). Partial epilepsy with or without generalization 629 (44.9%) was the most common type of epilepsies followed by generalized epilepsy 373 (26.6%) and epilepsy 326 (23.3%). Musculoskeletal pain 1017 (58.6%) was the most common presentation of myopathies. Vertigo was seen in 510 (3.11%) patients followed by Bell’s palsy 161 (0.98%). The frequency of the top neurological diseases seen in out-patient clinics are presented in Fig. 1. The frequencies of neurological diseases in patients above the age of 45 years are presented in Additional file 1. The prevalence of stroke was similar in both genders. Parkinson’s disease was more prevalent in males 564 (70.8%) than females 257 (62.1%); (p = 0.002). Epilepsies were seen more in males 737 (71.3%) as compared to females 665 (65.1%); (p = 0.003). Migraines 1231 (60.7%) versus 467 (45.4%) and vertigo disease 260 (61.6%) versus 249 (49.7%) were more common in females as compared to males; Table 2. Of the Parkinson’s disease patients 50.9% were between the ages of 45 and 65 years. A comparison of different disease and age groups is shown in Additional file 2.
Table 1

Diagnosis profile of the study population n = 16,371

Diagnosisn%
Vascular disease 284217.4
Stroke2792/284298.2
Types (n = 2729)
 Ischaemic stroke227781.6
 Transient stroke1706.1
 Haemorrhagic stroke29410.5
 Ischemia and hemorrhagic190.7
 Ischemia and transient301.1
 Transient and hemorrhage20.1
Cerebellar ataxias and hereditary spastic paraplegias 3111.9
Motor neuron diseases6019.2
Sleep disorders 195
Restless leg syndrome8744.6
Obstructive sleep apnoea10553.8
Headache disorders 3058 18.6
Type of headache (n = 1370)
 Headache disorder65121.2
 Tension type headache57418.7
 Cluster headache290.68
 Chronic headache282.04
 Headache due to psychiatric disorder261.89
 Headache attributed to head and/or neck trauma110.35
Migraine1698/305855.5
Acquire metabolic and toxic disorders 130.07
CNS infection 3140.01
Meningitis (n = 248)
Bacterial meningitis3212.9
Tuberculous meningitis/tuberculoma16265.3
Fungal meningitis62.4
Viral meningitis4417.7
Symptomatic meningitis41.6
CNS neoplasm 1510.92
Meningioma2717.8
Oligodendroglioma2315.2
Pituitary adenoma2013.2
Glioma159.9
Nerve and root lesion 231114.1
Cervical radiculopathy36915.9
Carpal tunnel syndrome1536.6
Diabetic polyneuropathy1295.5
Guillain–Barre syndrome(AIDP)944.0
Psychiatric disorders 191611.7
Depression148677.5
Anxiety1889.8
Conversion disorders864.4
Demyelinating diseases 1811.10
Multiple sclerosis121/1816.6
Dementias 4602.8
Alzheimer’s diseases21145.8
Dementia frontal/vascular20745
Myopathies/muscle disorders 1734 10.5
Musculoskeletal pain101758.6
Myasthenia gravis19010.9
Fibromyalgia19311.1
Myopathies/muscle disorders492.8
Neck strain392.2
Polymyositis331.9
Development disorders 81 0.49
Mental retardation1923.4
Movement disorders 1211 7.3
Parkinson’s diseases82167.7
Dystonias14111.6
Essential tremor897.3
Epilepsies 2055 12.5
Epilepsy32623.3
Partial epilepsy with or without generalization62944.9
Generalised epilepsy37326.6
Juvenile myoconic epilepsy553.9
Seizures 59128.7
Febrile seizures71.2
Seizures vs. Pseudoseizures132.2
Fits9115.4
Complex partial seizures30.5
Seizures43974.3
GTC (general tonic chronic seizures)162.7
Pseudoseizures122.7
 Non-epileptic seizures22.0
 Post traumatic seizures30.5
 Systematic seizures10.2
 Neonate seizure10.2
 Focal seizures20.3
 Syncopy vs. seizures10.2
Spinal disorders 1240.75
Myelitis6250
Myelopathy6250
Others
Bell palsy1610.98
Vertigo5103.11
Encephalopathy330.20
Neurometabolic/nutritional 1741.06
Vitamin D deficiency osteomalacic7241.3
B12 deficiency8045.9
Wilson disease2212.6
Fig. 1

The ten leading diseases in the out-patients neurology clinics

Table 2

Distribution of diagnosis among male and females

Male, n (%)Female, n (%) p value
Stroke, n = 27921795 (98.6)997 (97.6)0.052
Meningitis, n = 248127 (78.4)121 (80.1)0.78
Parkinson’s disease, n = 821564 (70.8)257 (62.1)0.002
Epilepsy, n = 1402737 (71.3)665 (65.1)0.003
Musculoskeletal pain, n = 1017471 (59.1)546 (58.3)0.73
Migraine, n = 1698467 (45.4)1231 (60.7)< 0.001
Vertigo, n = 510249 (49.7)260 (61.6)< 0.001
Alzheimer’s, n = 211106 (43.8)105 (48.2)0.35
Dementia, n = 207104 (43)103 (47.2)0.39
Obstructive sleep apnoea, n = 10560 (33.3)45 (34.4)0.90
Diagnosis profile of the study population n = 16,371 The ten leading diseases in the out-patients neurology clinics Distribution of diagnosis among male and females

Discussion

The study was designed to investigate the frequency of NDs in Pakistan. NDs commonly cause public health challenges, creating burdens and disability. In our study, the age group between 46 and 65 years represented 34% of all out-patient visits. A study from Dhaka, Bangladesh reported 59.7% of admissions in neurology were after the age of 40 years [11]. A study from Nigeria reported 40.8% were aged between 51 and 60 years [12]. The mean age of the study participants was 46 years which was similar to the mean age reported in other studies done in Pakistan [13], Bangladesh [11] and African countries [14-16]. Most patients were self-referrals and the leading diagnosis in our study were headache, stroke, epilepsies, depression, musculoskeletal pain, Parkinson’s, vertigo, cervical radiculopathy, dementia and meningitis. The leading cause of headache disorders is similar to the study by Alam et al. conducted in Peshawar, Pakistan [13], Anand et al. from India [17], and Callixte et al. from sub-Saharan Africa [16, 18]. The most common cause of out-patient visits was stroke (98.2%), which is similar to previous studies [11, 12, 14, 16, 19]. According to WHO estimates in 2001, 86% of deaths related to stroke worldwide occurred in developing countries [20]. A population-based study [21] from Pakistan showed a much higher prevalence of stroke 19,000 per 100,000 population (19·1%) in comparison with worldwide literature. A study from India estimates the prevalence of stroke ranges from 44 to 843 per 100,000 population [22]. Further studies are needed to determine the prevalence of stroke subtypes between Pakistani and Western populations [23]. Furthermore, meningitis was the second leading cause of out-patient clinic visit in our study. A prior study reported headache as the most common presentation, followed by cerebrovascular accidents and epilepsy [13]. A study from Bangladesh reported that stroke and seizures were the most seen diagnosis [11]. Other than meningitis, epilepsy was the most common neurological disorder and the highest prevalence is seen in people under 30 years of age [24]. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological disorders [25]. Neurodegenerative diseases are frequent in older populations. Meta-analysis of worldwide data showed the prevalence of Parkinson’s disease rising with age. An estimated 7 to 10 million people are living with Parkinson’s disease [26]. Prevalence differed by geographic location [27], however, dementia was seen both in young and older age groups [28]. The prevalence of dementia in South Asia is estimated to be 1.9% [29]. Alzheimer’s disease is responsible for 45.8% of admissions in our neurological setting. Mental illnesses in Pakistan depicts a gloomy picture with a 6% prevalence of depression, 1.5% schizophrenia, 1–2% epilepsy and 1% of Alzheimer’s disease [30]. Due to a lack of research, it is difficult to get an accurate number of people suffering from these diseases. Pakistan’s estimated population is over 194.9 million, making it one of the world’s most-populous countries. At least 10% of the population of Pakistan suffers from neurological diseases. More than 70% of medical colleges and almost 75% of government hospitals are without neurologists. Pakistan produces 10–20 neurologists annually out of which 50% leave the country. The present study lays a foundation of data regarding ND burden in this region to build a registry of data and address the gap in existing information about this neglected area of disease epidemiology.

Limitation

We had some limitations in this study. First, this study is a hospital-based design and patients were seen only once by the neurologist so follow up data was unavailable. Second, this study was conducted in an urban centre so the data is not necessarily representative of the whole country. Further studies involving large cohorts are required to validate these findings in both urban and rural populations. Additional file 1. The ten leading diseases in the out-patient neurology clinics. Leading diseases among patients above the age of 45 years. Additional file 2. Age wise distribution of diagnosis. Description of data: age wise distribution of leading diagnosis. Additional file 3. Demographic and clinical characteristics.
  19 in total

1.  The global burden of neurologic diseases.

Authors:  Jerome H Chin; Nirali Vora
Journal:  Neurology       Date:  2014-07-22       Impact factor: 9.910

2.  Pattern of neurological admissions in the tropics: experience at Abakaliki South-Eastern Nigeria.

Authors:  Chukwuemeka O Eze; Uma A Kalu
Journal:  Niger J Med       Date:  2014 Oct-Dec

3.  Pattern of neurological admissions in the tropics: Experience at Kano, Northwestern Nigeria.

Authors:  L F Owolabi; M Y Shehu; M N Shehu; J Fadare
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

Review 4.  Epidemiology of epilepsy in Pakistan: review of literature.

Authors:  I A Khatri; S T Iannaccone; M S Ilyas; M Abdullah; S Saleem
Journal:  J Pak Med Assoc       Date:  2003-12       Impact factor: 0.781

Review 5.  Stroke in South Asian countries.

Authors:  Mohammad Wasay; Ismail A Khatri; Subhash Kaul
Journal:  Nat Rev Neurol       Date:  2014-02-11       Impact factor: 42.937

Review 6.  The prevalence of Parkinson's disease: a systematic review and meta-analysis.

Authors:  Tamara Pringsheim; Nathalie Jette; Alexandra Frolkis; Thomas D L Steeves
Journal:  Mov Disord       Date:  2014-06-28       Impact factor: 10.338

7.  Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas.

Authors:  M Gourie-Devi; G Gururaj; P Satishchandra; D K Subbakrishna
Journal:  Neuroepidemiology       Date:  2004-08-05       Impact factor: 3.282

8.  The pattern of neurological diseases in elderly people in outpatient consultations in Sub-Saharan Africa.

Authors:  Kuate-Tegueu Callixte; Tchaleu Benjamin Clet; Doumbe Jacques; Yepnjio Faustin; Dartigues Jean François; Tabue-Teguo Maturin
Journal:  BMC Res Notes       Date:  2015-04-17

9.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Christopher J L Murray; Theo Vos; Rafael Lozano; Mohsen Naghavi; Abraham D Flaxman; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Diego Gonzalez-Medina; Richard Gosselin; Rebecca Grainger; Bridget Grant; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Francine Laden; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Daphna Levinson; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Charles Mock; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Natasha Wiebe; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

10.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  2 in total

Review 1.  An Updated List of Neuromedicinal Plants of Pakistan, Their Uses, and Phytochemistry.

Authors:  Abdul Waheed Khan; Arif-Ullah Khan; Syed Muhammad Mukarram Shah; Aziz Ullah; Muhammad Faheem; Muhammad Saleem
Journal:  Evid Based Complement Alternat Med       Date:  2019-03-03       Impact factor: 2.629

2.  Spectrum of neurological disorders in neurology outpatients clinics in urban and rural Sindh, Pakistan: a cross sectional study.

Authors:  Safia Awan; Alam Ibrahim Siddiqi; Ahmed Asif; Naveeduddin Ahmed; Hazim Brohi; Sajad Jalbani; Mohammad Wasay
Journal:  BMC Neurol       Date:  2019-08-13       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.